Building on the resounding success of our 2024 event, the Patient and Carers Congress 2025 is poised to be Europe’s premier and most impactful gathering yet. We’re raising the bar even higher – delivering world-class speakers, fully immersive experiences, and unmatched networking opportunities that will truly accelerate patient outcomes, therapies access and innovation for the community.

Bringing together communities across different types of cancer, Waldenström’s Macroglobulinemia and Myeloproliferative Neoplasms to Sickle Cell Disease, Myeloma, Chronic Myeloid Leukaemia, Chronic Lymphocytic Leukaemia, Acute Myeloid Leukaemia and more, the HPCC25 is set to create an energising atmosphere of learning and advancement. Shared experiences, expertise, and insights will catalyse innovations that increase the potential for developing safer, more effective medicines and care approaches.

Bigger in scale, bolder in vision, and elevated in impact – the HPCC25 promises to be an unmatched experience you won’t want to miss.